{"composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"Porcentaje de infecciones del torrente sangu\u00edneo debidas a determinados organismos resistentes a los antimicrobianos ","graph_titles":[],"graph_type":"line","indicator_name":"Porcentaje de infecciones del torrente sangu\u00edneo debidas a determinados organismos resistentes a los antimicrobianos ","indicator_number":"3.d.2","national_geographical_coverage":"","page_content":"","permalink":"","precision":[],"progress_status":"notstarted","reporting_status":"notstarted","sort":"","standalone":false,"tags":[],"indicador_disponible":"La CA de Euskadi no elabora estad\u00edsticas oficiales continuas con la metodolog\u00eda del indicador","definicion":null,"formula":null,"desagregacion":null,"periodicidad":null,"observaciones":null,"justificacion_global":"\nLa resistencia a los antimicrobianos (RAM) es una amenaza mundial para la salud, \nlos medios de vida, la seguridad alimentaria y el logro de muchos de los Objetivos \nde Desarrollo Sostenible. Los antibi\u00f3ticos, antivirales, agentes antiparasitarios \ny antif\u00fangicos son cada vez m\u00e1s ineficaces debido a la resistencia desarrollada \npor su uso excesivo o inadecuado, con graves consecuencias para la salud humana y \nanimal (terrestre y acu\u00e1tica) y la salud de las plantas, e impactos negativos en \nla producci\u00f3n de alimentos, el medio ambiente y la econom\u00eda mundial. \n\nEn particular, la resistencia a los antimicrobianos afectar\u00e1 negativamente \nel logro de muchas de las metas enumeradas en el Objetivo 3 debido a la \nreducci\u00f3n de las opciones de tratamiento para las infecciones por \npat\u00f3genos resistentes; afectar\u00e1 a las metas del Objetivo 2 al afectar \nla productividad agr\u00edcola, incluida la producci\u00f3n de animales destinados \nal consumo; y afectar\u00e1 a las metas del Objetivo 1, ya que el aumento de \nla resistencia a los antimicrobianos dar\u00e1 lugar a grandes disminuciones \ndel crecimiento econ\u00f3mico, aumentar\u00e1 la desigualdad econ\u00f3mica y llevar\u00e1 \na otros 24 millones de personas a la pobreza extrema para 2030. \n\nFuente: Divisi\u00f3n de Estad\u00edsticas de las Naciones Unidas\n","dato_global":"\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_MRSA&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Porcentaje de infecci\u00f3n del torrente sangu\u00edneo debida a Staphylococcus aureus resistente a la meticilina (SARM) entre pacientes que buscan atenci\u00f3n y cuya muestra de sangre se toma y analiza (%) SH_BLD_MRSA</a> UNSTATS\n\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_ECOLI&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Porcentaje de infecci\u00f3n del torrente sangu\u00edneo debido a Escherichia coli resistente a cefalosporinas de tercera generaci\u00f3n (p. ej., ESBL-E. coli) entre pacientes que buscan atenci\u00f3n y cuya muestra de sangre se toma y analiza (%) SH_BLD_ECOLI</a> UNSTATS\n","comparabilidad":null,"indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf\">Metadatos 3-d-2.pdf</a> (solo en ingl\u00e9s)","national_data_updated_date":"","national_metadata_updated_date":"2025-06-18","en":{"indicador_disponible":"La CA de Euskadi no elabora estad\u00edsticas oficiales continuas con la metodolog\u00eda del indicador","definicion":null,"formula":null,"desagregacion":null,"periodicidad":null,"observaciones":null,"justificacion_global":"\nAntimicrobial resistance (AMR) is a global threat to health, livelihoods, \nfood security and the achievement of many of the Sustainable Development \nGoals. Antibiotics, antivirals, antiparasitic agents and antifungals are \nincreasingly ineffective owing to resistance developed through their excessive \nor inappropriate use, with serious consequences for human and animal health \n(terrestrial and aquatic), and plant health, and negative impacts on food production, \nthe environment and the global economy. \n\nIn particular, antimicrobial resistance will negatively impact the achievement \nof many of the targets listed under Goal 3 due to reduced treatment options for \ninfections by resistant pathogens; will impact targets under Goal 2 by impacting \nthe agricultural productivity, including food animal production; and will impact \ntargets in Goal 1 as increased antimicrobial resistance will result in large declines \nin economic growth, increase economic inequality and drive an additional 24 million \npeople into extreme poverty by 2030. \n\nSource: United Nations Statistics Division\n","dato_global":"\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_MRSA&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%) SH_BLD_MRSA</a> UNSTATS\n\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_ECOLI&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) SH_BLD_ECOLI</a> UNSTATS\n","comparabilidad":null,"indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf\">Metadata 3-d-2.pdf</a>","informacion_interes":null,"national_data_updated_date":"2024-10-29","national_metadata_updated_date":"2024-10-29"},"target_number":"3.d","goal_number":"3","indicator_sort_order":"03-0d-02"}